These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


195 related items for PubMed ID: 8669042

  • 1. [Radiotherapy and/or chemotherapy in children with primitive neuroectodermal tumor (PNET) of the pineal region].
    Dunst J.
    Strahlenther Onkol; 1996 Feb; 172(2):108-9. PubMed ID: 8669042
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of children with central nervous system primitive neuroectodermal tumors/pinealoblastomas in the prospective multicentric trial HIT 2000 using hyperfractionated radiation therapy followed by maintenance chemotherapy.
    Gerber NU, von Hoff K, Resch A, Ottensmeier H, Kwiecien R, Faldum A, Matuschek C, Hornung D, Bremer M, Benesch M, Pietsch T, Warmuth-Metz M, Kuehl J, Rutkowski S, Kortmann RD.
    Int J Radiat Oncol Biol Phys; 2014 Jul 15; 89(4):863-71. PubMed ID: 24969797
    [Abstract] [Full Text] [Related]

  • 3. Differential responsiveness among "high risk" pediatric brain tumors in a pilot study of dose-intensive induction chemotherapy.
    Jennings MT, Cmelak A, Johnson MD, Moots PL, Pais R, Shyr Y.
    Pediatr Blood Cancer; 2004 Jul 15; 43(1):46-54. PubMed ID: 15170889
    [Abstract] [Full Text] [Related]

  • 4. The potential for complete and durable response in nonglial primary brain tumors in children and young adults with enhanced chemotherapy delivery.
    Dahlborg SA, Petrillo A, Crossen JR, Roman-Goldstein S, Doolittle ND, Fuller KH, Neuwelt EA.
    Cancer J Sci Am; 1998 Jul 15; 4(2):110-24. PubMed ID: 9532413
    [Abstract] [Full Text] [Related]

  • 5. Radiation is an important component of multimodality therapy for pediatric non-pineal supratentorial primitive neuroectodermal tumors.
    McBride SM, Daganzo SM, Banerjee A, Gupta N, Lamborn KR, Prados MD, Berger MS, Wara WM, Haas-Kogan DA.
    Int J Radiat Oncol Biol Phys; 2008 Dec 01; 72(5):1319-23. PubMed ID: 18485615
    [Abstract] [Full Text] [Related]

  • 6. Prognostic factors and treatment results for supratentorial primitive neuroectodermal tumors in children using radiation and chemotherapy: a Childrens Cancer Group randomized trial.
    Cohen BH, Zeltzer PM, Boyett JM, Geyer JR, Allen JC, Finlay JL, McGuire-Cullen P, Milstein JM, Rorke LB, Stanley P.
    J Clin Oncol; 1995 Jul 01; 13(7):1687-96. PubMed ID: 7602359
    [Abstract] [Full Text] [Related]

  • 7. [Survival of children with primitive neuroectodermal tumors and malignant ependymomas of the central nervous system after treatment with 8 cytostatic agents in one day. A report of the Children's Cancer Group].
    Röttinger EM.
    Strahlenther Onkol; 1995 May 01; 171(5):303-4. PubMed ID: 7770788
    [No Abstract] [Full Text] [Related]

  • 8. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.
    Thorarinsdottir HK, Rood B, Kamani N, Lafond D, Perez-Albuerne E, Loechelt B, Packer RJ, MacDonald TJ.
    Pediatr Blood Cancer; 2007 Mar 01; 48(3):278-84. PubMed ID: 16456857
    [Abstract] [Full Text] [Related]

  • 9. [Effectiveness of intensive chemotherapy in the treatment of medulloblastoma/primitive neuroectodermal tumor in children].
    Konoplia NE, Strongin IuS, Talabaev MV, Aleĭnikova OV.
    Vopr Onkol; 2008 Mar 01; 54(2):157-63. PubMed ID: 18522163
    [Abstract] [Full Text] [Related]

  • 10. Supratentorial primitive neuroectodermal tumors (S-PNET) in children: A prospective experience with adjuvant intensive chemotherapy and hyperfractionated accelerated radiotherapy.
    Massimino M, Gandola L, Spreafico F, Luksch R, Collini P, Giangaspero F, Simonetti F, Casanova M, Cefalo G, Pignoli E, Ferrari A, Terenziani M, Podda M, Meazza C, Polastri D, Poggi G, Ravagnani F, Fossati-Bellani F.
    Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1031-7. PubMed ID: 16343801
    [Abstract] [Full Text] [Related]

  • 11. Patterns of failure in supratentorial primitive neuroectodermal tumors treated in Children's Cancer Group Study 921, a phase III combined modality study.
    Hong TS, Mehta MP, Boyett JM, Donahue B, Rorke LB, Yao MS, Zeltzer PM.
    Int J Radiat Oncol Biol Phys; 2004 Sep 01; 60(1):204-13. PubMed ID: 15337557
    [Abstract] [Full Text] [Related]

  • 12. Brain magnetic resonance imaging after high-dose chemotherapy and radiotherapy for childhood brain tumors.
    Spreafico F, Gandola L, Marchianò A, Simonetti F, Poggi G, Adduci A, Clerici CA, Luksch R, Biassoni V, Meazza C, Catania S, Terenziani M, Musumeci R, Fossati-Bellani F, Massimino M.
    Int J Radiat Oncol Biol Phys; 2008 Mar 15; 70(4):1011-9. PubMed ID: 17904307
    [Abstract] [Full Text] [Related]

  • 13. [Current and future strategies in interdisciplinary treatment of medulloblastomas, supratentorial PNET (primitive neuroectodermal tumors) and intracranial germ cell tumors in childhood].
    Kortmann RD, Kühl J, Timmermann B, Calaminus G, Dieckmann K, Wurm R, Sörensen N, Urban C, Göbel U, Bamberg M.
    Strahlenther Onkol; 2001 Sep 15; 177(9):447-61. PubMed ID: 11591018
    [Abstract] [Full Text] [Related]

  • 14. High-dose chemotherapy and autologous hematopoietic progenitor cell rescue in children with recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors: the impact of prior radiotherapy on outcome.
    Butturini AM, Jacob M, Aguajo J, Vander-Walde NA, Villablanca J, Jubran R, Erdreich-Epstein A, Marachelian A, Dhall G, Finlay JL.
    Cancer; 2009 Jul 01; 115(13):2956-63. PubMed ID: 19402050
    [Abstract] [Full Text] [Related]

  • 15. The treatment of malignant brain tumors in infants and very young children: an update of the Pediatric Oncology Group experience.
    Duffner PK, Horowitz ME, Krischer JP, Burger PC, Cohen ME, Sanford RA, Friedman HS, Kun LE.
    Neuro Oncol; 1999 Apr 01; 1(2):152-61. PubMed ID: 11554387
    [No Abstract] [Full Text] [Related]

  • 16. Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed supratentorial primitive neuroectodermal tumors (sPNETs): report of the Head Start I and II experience.
    Fangusaro J, Finlay J, Sposto R, Ji L, Saly M, Zacharoulis S, Asgharzadeh S, Abromowitch M, Olshefski R, Halpern S, Dubowy R, Comito M, Diez B, Kellie S, Hukin J, Rosenblum M, Dunkel I, Miller DC, Allen J, Gardner S.
    Pediatr Blood Cancer; 2008 Feb 01; 50(2):312-8. PubMed ID: 17668858
    [Abstract] [Full Text] [Related]

  • 17. Therapy and outcome of orbital primitive neuroectodermal tumor.
    Bakhshi S, Meel R, Naqvi SG, Mohanti BK, Kashyap S, Pushker N, Sen S.
    Pediatr Blood Cancer; 2009 Apr 01; 52(4):544-7. PubMed ID: 19090547
    [Abstract] [Full Text] [Related]

  • 18. Patterns of treatment failure in infants with primitive neuroectodermal tumors who were treated on CCG-921: a phase III combined modality study.
    Hong TS, Mehta MP, Boyett JM, Donahue B, Rorke LB, Zeltzer PM.
    Pediatr Blood Cancer; 2005 Oct 15; 45(5):676-82. PubMed ID: 16007595
    [Abstract] [Full Text] [Related]

  • 19. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group.
    Geyer JR, Sposto R, Jennings M, Boyett JM, Axtell RA, Breiger D, Broxson E, Donahue B, Finlay JL, Goldwein JW, Heier LA, Johnson D, Mazewski C, Miller DC, Packer R, Puccetti D, Radcliffe J, Tao ML, Shiminski-Maher T, Children's Cancer Group.
    J Clin Oncol; 2005 Oct 20; 23(30):7621-31. PubMed ID: 16234523
    [Abstract] [Full Text] [Related]

  • 20. Non-pineal supratentorial primitive neuro-ectodermal tumors (sPNET) in teenagers and young adults: Time to reconsider cisplatin based chemotherapy after cranio-spinal irradiation?
    Biswas S, Burke A, Cherian S, Williams D, Nicholson J, Horan G, Jefferies S, Williams M, Earl HM, Burnet NG, Hatcher H.
    Pediatr Blood Cancer; 2009 Jul 20; 52(7):796-803. PubMed ID: 19202566
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.